| PUBMED |
“dabigatran”[MeSH Terms] OR “dabigatran”[Title/Abstract] OR “Pradaxa”[Title/Abstract] OR “rivaroxaban”[MeSH Terms] OR “rivaroxaban”[Title/Abstract] OR “Xarelto”[Title/Abstract] OR “apixaban” [MeSH Terms] OR “apixaban”[Title/Abstract] OR “Eliquis”[Title/Abstract] OR “edoxaban”[MeSH Terms] OR “edoxaban”[Title/Abstract] OR “Savaysa”[Title/Abstract]) OR “betrixaban”[MeSH Terms] OR “betrixaban”[Title/Abstract] OR “Bevyxxa”[Title/Abstract]) OR “Non-vitamin K antagonist oral anticoagulants”[Title/Abstract] OR “NOACs”[Title/Abstract]) OR “direct oral anticoagulants”[Title/Abstract]) OR “DOACs”[Title/Abstract]) OR “novel oral anticoagulants”[Title/Abstract]) OR “new oral anticoagulants”[Title/Abstract]) OR “factor Xa inhibitors”[Title/Abstract]) OR “factor IIa inhibitors”[Title/Abstract] AND “cancer”[MeSH Terms] OR “cancer”[Title/Abstract] OR “neoplasia”[Title/Abstract] OR “neoplasm”[Title/Abstract] OR “tumor”[Title/Abstract] OR “malignancy”[Title/Abstract] |
449 |
| EMBASE |
‘dabigatran’/exp OR ‘dabigatran’: ti,ab,kw OR ‘Pradaxa’: ti,ab,kw OR ‘rivaroxaban’/exp OR ‘rivaroxaban’: ti,ab,kw OR ‘Xarelto’: ti,ab,kw OR ‘apixaban’/exp OR ‘apixaban’: ti,ab,kw OR ‘Eliquis’: ti,ab,kw OR edoxaban’/exp OR ‘edoxaban’: ti,ab,kw OR ‘Savaysa’: ti,ab,kw OR ‘betrixaban’/exp OR ‘betrixaban’: ti,ab,kw OR ‘Bevyxxa’: ti,ab,kw OR ‘Non-vitamin K antagonist oral anticoagulants’: ti,ab,kw OR ‘NOACs’: ti,ab,kw OR ‘direct oral anticoagulants’: ti,ab,kw OR ‘DOACs’: ti,ab,kw OR ‘novel oral anticoagulants’: ti,ab,kw OR ‘new oral anticoagulants’: ti,ab,kw OR ‘factor Xa inhibitors’: ti,ab,kw OR ‘factor IIa inhibitors’: ti,ab,kw AND ‘cancer’: ti,ab,kw OR ‘neoplasia’: ti,ab,kw OR ‘neoplasm’: ti,ab,kw OR ‘tumor’: ti,ab,kw OR ‘malignancy’: ti,ab,kw |
1,125 |
| COCHRANE |
MeSH descriptor: [dabigatran] OR dabigatran: ti,ab,kw OR Pradaxa: ti,ab,kw OR MeSH descriptor: [rivaroxaban] OR rivaroxaban: ti,ab,kw OR Xarelto: ti,ab,kw OR MeSH descriptor: [apixaban] OR apixaban: ti,ab,kw OR Eliquis: ti,ab,kw OR MeSH descriptor: [edoxaban] OR edoxaban: ti,ab,kw OR Savaysa: ti,ab,kw OR MeSH descriptor: [betrixaban] OR betrixaban: ti,ab,kw OR Bevyxxa: ti,ab,kw OR Non-vitamin K antagonist oral anticoagulants: ti,ab,kw OR NOACs: ti,ab,kw OR direct oral anticoagulants: ti,ab,kw OR DOACs: ti,ab,kw OR novel oral anticoagulants: ti,ab,kw OR new oral anticoagulants: ti,ab,kw OR factor Xa inhibitors: ti,ab,kw OR factor IIa inhibitors: ti,ab,kw AND MeSH descriptor: [cancer] OR cancer: ti,ab,kw OR neoplasia: ti,ab,kw OR neoplasm: ti,ab,kw OR tumor: ti,ab,kw OR malignancy: ti,ab,kw |
180 |
| Overall |
|
1,754 |
| Duplication |
|
369 |
